These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30566560)

  • 1. Gemcitabine-induced pseudocellulitis.
    Caplan A; Chu DH; Rosenbach M; Svoboda J
    Cutis; 2018 Nov; 102(5):E20-E23. PubMed ID: 30566560
    [No Abstract]   [Full Text] [Related]  

  • 2. Recurrent pseudocellulitis due to gemcitabine: underrecognized and underreported?
    Dasanu CA; Bockorny B
    J Oncol Pharm Pract; 2015 Oct; 21(5):377-9. PubMed ID: 24769519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gemcitabine-related "pseudocellulitis": report of 2 cases and review of the literature.
    Tan DH; Bunce PE; Liles WC; Gold WL
    Clin Infect Dis; 2007 Sep; 45(5):e72-6. PubMed ID: 17682983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gemcitabine associated pseudocellulitis.
    Singh A; Hampole H
    J Gen Intern Med; 2012 Dec; 27(12):1721. PubMed ID: 22696254
    [No Abstract]   [Full Text] [Related]  

  • 5. A rash diagnosis: Gemcitabine-associated pseudocellulitis.
    Strouse C; Epperla N
    J Oncol Pharm Pract; 2017 Mar; 23(2):157-160. PubMed ID: 26946530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gemcitabine-induced pseudocellulitis: a case report and review of the literature.
    Bami H; Goodman C; Boldt G; Vincent M
    Curr Oncol; 2019 Oct; 26(5):e703-e706. PubMed ID: 31708665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gemcitabine associated pseudocellulitis: A missed diagnosis.
    Gill D; Schrader J; Kelly M; Martinez F; Syed W; Wright J
    J Oncol Pharm Pract; 2018 Oct; 24(7):550-552. PubMed ID: 28714381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gemcitabine-Induced Pseudocellulitis in a Patient With Recurrent Lymphedema: A Case Report and Review of the Current Literature.
    Curtis S; Hong S; Gucalp R; Calvo M
    Am J Ther; 2016; 23(1):e321-3. PubMed ID: 24451298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gemcitabine-associated "pseudocellulitis" and "pseudosepsis": a case report and review of the literature.
    Obeid KM; Venugopal AA
    Am J Ther; 2013 Jan; 20(1):118-20. PubMed ID: 21768869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent lower extremity pseudocellulitis.
    Korniyenko A; Lozada J; Ranade A; Sandhu G
    Am J Ther; 2012 Jul; 19(4):e141-2. PubMed ID: 22772033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy-Induced Pseudocellulitis Without Prior Radiation Exposure: A Systematic Review.
    Kovacs LD; O'Donoghue M; Cogen AL
    JAMA Dermatol; 2023 Aug; 159(8):870-874. PubMed ID: 37379014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gemcitabine: cutaneous, hepatic and vascular disorders.
    Prescrire Int; 2009 Jun; 18(101):122. PubMed ID: 19637433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy with gemcitabine in pretreated peripheral T-cell lymphoma patients.
    Zinzani PL; Magagnoli M; Bendandi M; Orcioni GF; Gherlinzoni F; Albertini P; Pileri SA; Tura S
    Ann Oncol; 1998 Dec; 9(12):1351-3. PubMed ID: 9932168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of gemcitabine-related acute lipodermatosclerosis.
    Nyckowski T; McGregor S; Huang WW
    J Oncol Pharm Pract; 2019 Jul; 25(5):1271-1274. PubMed ID: 30041585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent cutaneous toxic erythema induced by gemcitabine in a patient with pancreatic cancer.
    Li J; Ko CJ; Saif MW
    Cutan Ocul Toxicol; 2009; 28(3):144-8. PubMed ID: 19527102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Widespread Skin Necrosis Secondary to Gemcitabine Therapy.
    Zito PM; Gonzalez AM; Fox JD; Cronin M; Mackrides N; Kirsner RS; Nichols AJ
    J Drugs Dermatol; 2018 May; 17(5):582-585. PubMed ID: 29742194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erysipeloid skin toxicity induced by gemcitabine.
    Zustovich F; Pavei P; Cartei G
    J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):757-8. PubMed ID: 16836522
    [No Abstract]   [Full Text] [Related]  

  • 18. Livedo racemosa and hemolytic uremic syndrome induced by gemcitabine.
    Tognetti L; Garosi G; Rongioletti F; Fimiani M; Rubegni P
    Int J Dermatol; 2016 Oct; 55(10):e555-6. PubMed ID: 27125732
    [No Abstract]   [Full Text] [Related]  

  • 19. Gemcitabine-induced acute lipodermatosclerosis-like reaction.
    Chu CY; Yang CH; Chiu HC
    Acta Derm Venereol; 2001; 81(6):426-8. PubMed ID: 11859947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cumulative incidence of gemcitabine-induced thrombotic microangiopathy.
    Arnadottir M; Benediktsson T; Hrafnkelsson J
    Acta Oncol; 2007; 46(4):545-6. PubMed ID: 17497322
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.